跳至主要内容
临床试验/SLCTR/2015/023
SLCTR/2015/023招募中2 期

A randomized controlled, double blinded, clinical trial investigating the effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic fatty liver disease

Armed Forces Institute of Pathology, Pakistan0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of both genders aged 20 years and above.
  • 2. Ultrasound-proven fatty liver
  • 3. Fatty Liver Index (FLI) score of equal to or more than 60
  • 4. Mild to moderate elevation of alanine transaminase (ALT) and aspartate transaminase (AST) i.e. not greater than four times the upper limit of 42 IU/L and 37 IU/L respectively

排除标准

  • 1. Chronic hepatitis B and C
  • 2. Alcoholic fatty liver disease
  • 3. Any other acute or chronic illness including cancer
  • 4. Autoimmune liver disease
  • 5. Patients receiving other medications including herbal or vitamin supplements

研究者

发起方
Armed Forces Institute of Pathology, Pakistan

相似试验